Vaccine News and Research

Latest Vaccine News and Research

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

Study shows how MS patients treated with Rituximab react to COVID-19 vaccination

12 May 2022
Phase 1 clinical trial of vaccine for rare but deadly mosquito-borne viruses shows promising results

Phase 1 clinical trial of vaccine for rare but deadly mosquito-borne viruses shows promising results

12 May 2022
KHN’s ‘What the Health?’: The invisible pandemic

KHN’s ‘What the Health?’: The invisible pandemic

12 May 2022
Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

12 May 2022
Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

12 May 2022
Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

12 May 2022
COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

12 May 2022
Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

12 May 2022
SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

12 May 2022
Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

12 May 2022
Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

12 May 2022
Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

12 May 2022
SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

12 May 2022
The promise of RNA medicine is targeted and personalized

The promise of RNA medicine is targeted and personalized

11 May 2022
UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

11 May 2022
Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

11 May 2022
Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

11 May 2022
Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

11 May 2022
Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

11 May 2022
Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

11 May 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback